SRPT · Sarepta Therapeutics Inc. Common Stock (DE)
View on chartInsiders & Stakes
| Richard Barry President & CEO | ▲ Buy | Grant | 2,983,542 Shares held | 6/4/2026 | View profile |
| Douglas S. Ingram President & CEO | ▲ Buy | Grant | 929,391 Shares held | 12/7/2025 | View profile |
| Michael Severino Director | ▲ Buy | Grant | 756,104 Shares held | 7/28/2026 | View profile |
| M. Kathleen Behrens Director | ▲ Buy | Grant | 214,357 Shares held | 6/4/2026 | View profile |
| Louise Rodino-Klapac Chief Scientific Officer | ▼ Sell | Tax Withholding | 203,900 Shares held | 9/4/2026 | View profile |
| Ian Michael Estepan Chief Financial Officer | ▼ Sell | Tax Withholding | 177,184 Shares held | 9/4/2026 | View profile |
| Ryan Ho-Yan Wong Chief Financial Officer | ▼ Sell | Tax Withholding | 121,792 Shares held | 9/4/2026 | View profile |
| Cristin Rothfuss EVP, General Counsel | ▼ Sell | Tax Withholding | 115,519 Shares held | 9/4/2026 | View profile |
| Claude Nicaise Director | ▲ Buy | Grant | 48,407 Shares held | 6/4/2026 | View profile |
| Hans Lennart Rudolf Wigzell Director | ▲ Buy | Grant | 42,098 Shares held | 6/4/2026 | View profile |
| Murray Dallan Chief Customer Officer | ▲ Buy | Grant | 38,202 Shares held | 3/10/2025 | View profile |
| Arif Bilal Chief Tech Ops Officer | ▲ Buy | Grant | 32,500 Shares held | 3/10/2025 | View profile |
| Michael Andrew Chambers Director | ▲ Buy | Grant | 27,535 Shares held | 6/4/2026 | View profile |
| Kathryn Jean Boor Director | ▲ Buy | Grant | 25,138 Shares held | 6/4/2026 | View profile |
| Deirdre P. Connelly | ▲ Buy | Grant | 22,100 Shares held | 6/4/2026 | View profile |
| Ciambrone William EVP | ▲ Buy | Grant | 22,099 Shares held | 3/7/2022 | View profile |
| Stephen Mayo Director | ▲ Buy | Grant | 18,640 Shares held | 6/4/2026 | View profile |
| Brown Ryan Edward SVP, General Counsel | ▼ Sell | Open Market | 17,129 Shares held | 6/25/2024 | View profile |
| Mary Ann Gray Director | ▲ Buy | Grant | 12,356 Shares held | 3/7/2022 | View profile |
Transaction History
| Ryan Ho-Yan Wong | ▼ Sell | Tax Withholding | 13,272 | $295K | 9/4/2026 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 24,799 | $551K | 9/4/2026 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 22,025 | $489K | 9/4/2026 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 21,423 | $476K | 9/4/2026 |
| Michael Severino | ▲ Buy | Grant | 756,104 | — | 7/28/2026 |
| Kathryn Jean Boor | ▲ Buy | Grant | 16,875 | — | 6/4/2026 |
| Stephen Mayo | ▲ Buy | Grant | 16,875 | — | 6/4/2026 |
| Hans Lennart Rudolf Wigzell | ▲ Buy | Grant | 16,875 | — | 6/4/2026 |
| M. Kathleen Behrens | ▲ Buy | Grant | 16,875 | — | 6/4/2026 |
| Deirdre P. Connelly | ▲ Buy | Grant | 16,875 | — | 6/4/2026 |
| Claude Nicaise | ▲ Buy | Grant | 16,875 | — | 6/4/2026 |
| Michael Andrew Chambers | ▲ Buy | Grant | 16,875 | — | 6/4/2026 |
| Richard Barry | ▲ Buy | Grant | 16,875 | — | 6/4/2026 |
| Stephen Mayo | ▼ Sell | Open Market | 7,239 | $123K | 3/12/2026 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 974 | $17K | 3/11/2026 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 1,097 | $19K | 3/11/2026 |
| Ryan Ho-Yan Wong | ▼ Sell | Tax Withholding | 256 | $4K | 3/11/2026 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 948 | $16K | 3/11/2026 |
| Ryan Ho-Yan Wong | ▼ Sell | Tax Withholding | 162 | $3K | 3/9/2026 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 895 | $15K | 3/9/2026 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 1,036 | $18K | 3/9/2026 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 583 | $10K | 3/9/2026 |
| Ryan Ho-Yan Wong | ▼ Sell | Tax Withholding | 113 | $2K | 3/9/2026 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 484 | $8K | 3/9/2026 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 346 | $6K | 3/9/2026 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 504 | $9K | 3/9/2026 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 408 | $7K | 3/2/2026 |
| Ryan Ho-Yan Wong | ▼ Sell | Tax Withholding | 450 | $7K | 3/2/2026 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 3,301 | $53K | 3/2/2026 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 875 | $14K | 3/2/2026 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 3,718 | $60K | 3/2/2026 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 767 | $12K | 3/2/2026 |
| Ian Michael Estepan | ▲ Buy | Option Exercise | 8,125 | — | 3/1/2026 |
| Louise Rodino-Klapac | ▲ Buy | Option Exercise | 8,125 | — | 3/1/2026 |
| Ian Michael Estepan | ▲ Buy | Option Exercise | 2,069 | $28K | 2/26/2026 |
| Ian Michael Estepan | ▲ Buy | Option Exercise | 5,381 | $74K | 2/26/2026 |
| Claude Nicaise | ▲ Buy | Option Exercise | 10,500 | $144K | 1/29/2026 |
| Claude Nicaise | ▼ Sell | Tax Withholding | 6,780 | $144K | 1/29/2026 |
| M. Kathleen Behrens | ▲ Buy | Option Exercise | 10,500 | $144K | 1/27/2026 |
| M. Kathleen Behrens | ▼ Sell | Tax Withholding | 6,494 | $144K | 1/27/2026 |
| Ian Michael Estepan | ▼ Sell | Open Market | 13,187 | $294K | 12/16/2025 |
| Douglas S. Ingram | ▲ Buy | Grant | 50,000 | $0 | 12/7/2025 |
| Douglas S. Ingram | ▲ Buy | Grant | 50,000 | $0 | 12/7/2025 |
| Douglas S. Ingram | ▲ Buy | Grant | 73,001 | $0 | 12/7/2025 |
| Douglas S. Ingram | ▲ Buy | Grant | 269,542 | $0 | 12/7/2025 |
| Douglas S. Ingram | ▲ Buy | Grant | 96,541 | $0 | 12/7/2025 |
| Ryan Ho-Yan Wong | ▼ Sell | Tax Withholding | 80 | $2K | 12/1/2025 |
| Ryan Ho-Yan Wong | ▼ Sell | Tax Withholding | 78 | $2K | 12/1/2025 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 229 | $5K | 11/28/2025 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 4,582 | $84K | 11/17/2025 |
| Ian Michael Estepan | ▲ Buy | Grant | 50,000 | $0 | 9/3/2025 |
| Louise Rodino-Klapac | ▲ Buy | Grant | 93,875 | $0 | 9/3/2025 |
| Ryan Ho-Yan Wong | ▲ Buy | Grant | 93,875 | $0 | 9/3/2025 |
| Ryan Ho-Yan Wong | ▲ Buy | Grant | 25,000 | $0 | 9/3/2025 |
| Cristin Rothfuss | ▲ Buy | Grant | 25,000 | $0 | 9/3/2025 |
| Ian Michael Estepan | ▲ Buy | Grant | 93,875 | $0 | 9/3/2025 |
| Cristin Rothfuss | ▲ Buy | Grant | 93,875 | $0 | 9/3/2025 |
| Louise Rodino-Klapac | ▲ Buy | Grant | 50,000 | $0 | 9/3/2025 |
| Ryan Ho-Yan Wong | ▼ Sell | Tax Withholding | 327 | $5K | 7/31/2025 |
| Richard Barry | ▲ Buy | Option Exercise | 12,350 | $403K | 5/16/2025 |
| Richard Barry | ▲ Buy | Option Exercise | 9,746 | $245K | 5/13/2025 |
| Richard Barry | ▲ Buy | Option Exercise | 10,500 | $144K | 5/13/2025 |
| Claude Nicaise | ▲ Buy | Option Exercise | 9,746 | $245K | 3/12/2025 |
| Claude Nicaise | ▼ Sell | Open Market | 2,491 | $248K | 3/12/2025 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 491 | $49K | 3/10/2025 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 1,051 | $105K | 3/10/2025 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 2,890 | $289K | 3/10/2025 |
| Arif Bilal | ▼ Sell | Tax Withholding | 523 | $52K | 3/10/2025 |
| Stephen Mayo | ▲ Buy | Grant | 2,383 | — | 3/10/2025 |
| Ian Michael Estepan | ▲ Buy | Grant | 8,276 | — | 3/10/2025 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 2,539 | $254K | 3/10/2025 |
| Murray Dallan | ▼ Sell | Tax Withholding | 996 | $100K | 3/10/2025 |
| Murray Dallan | ▼ Sell | Tax Withholding | 2,737 | $274K | 3/10/2025 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 924 | $93K | 3/10/2025 |
| Kathryn Jean Boor | ▲ Buy | Grant | 2,383 | — | 3/10/2025 |
| Hans Lennart Rudolf Wigzell | ▲ Buy | Grant | 2,383 | — | 3/10/2025 |
| Claude Nicaise | ▲ Buy | Grant | 2,383 | — | 3/10/2025 |
| Cristin Rothfuss | ▲ Buy | Grant | 8,276 | — | 3/10/2025 |
| Louise Rodino-Klapac | ▲ Buy | Grant | 8,276 | — | 3/10/2025 |
| M. Kathleen Behrens | ▲ Buy | Grant | 2,383 | — | 3/10/2025 |
| Richard Barry | ▲ Buy | Grant | 2,383 | $0 | 3/10/2025 |
| Murray Dallan | ▲ Buy | Grant | 8,276 | — | 3/10/2025 |
| Michael Andrew Chambers | ▲ Buy | Grant | 2,383 | — | 3/10/2025 |
| Arif Bilal | ▲ Buy | Grant | 8,276 | — | 3/10/2025 |
| Deirdre P. Connelly | ▲ Buy | Grant | 2,383 | — | 3/10/2025 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 585 | $61K | 3/7/2025 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 514 | $53K | 3/7/2025 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 7,990 | $829K | 3/7/2025 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 1,131 | $117K | 3/7/2025 |
| Murray Dallan | ▼ Sell | Tax Withholding | 8,613 | $893K | 3/7/2025 |
| Arif Bilal | ▼ Sell | Tax Withholding | 508 | $53K | 3/7/2025 |
| Arif Bilal | ▼ Sell | Tax Withholding | 8,527 | $884K | 3/7/2025 |
| Louise Rodino-Klapac | ▲ Buy | Option Exercise | 5,500 | — | 3/7/2025 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 9,094 | $943K | 3/7/2025 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 347 | $36K | 3/7/2025 |
| Murray Dallan | ▼ Sell | Tax Withholding | 549 | $57K | 3/7/2025 |
| Murray Dallan | ▲ Buy | Option Exercise | 5,500 | — | 3/7/2025 |
| Ian Michael Estepan | ▲ Buy | Option Exercise | 5,500 | — | 3/7/2025 |
| Ian Michael Estepan | ▲ Buy | Option Exercise | 17,500 | — | 3/6/2025 |
| Arif Bilal | ▲ Buy | Option Exercise | 17,500 | — | 3/6/2025 |
| Murray Dallan | ▲ Buy | Option Exercise | 17,500 | — | 3/6/2025 |
| Louise Rodino-Klapac | ▲ Buy | Option Exercise | 17,500 | — | 3/6/2025 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 296 | $30K | 3/4/2025 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 288 | $29K | 3/4/2025 |
| Arif Bilal | ▼ Sell | Tax Withholding | 281 | $28K | 3/4/2025 |
| Arif Bilal | ▼ Sell | Tax Withholding | 233 | $24K | 3/4/2025 |
| Murray Dallan | ▼ Sell | Tax Withholding | 1,685 | $171K | 3/4/2025 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 1,370 | $139K | 3/4/2025 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 1,704 | $173K | 3/4/2025 |
| Arif Bilal | ▼ Sell | Tax Withholding | 719 | $75K | 3/3/2025 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 557 | $58K | 3/3/2025 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 715 | $74K | 3/3/2025 |
| Cristin Rothfuss | ▼ Sell | Tax Withholding | 391 | $41K | 3/3/2025 |
| Murray Dallan | ▼ Sell | Tax Withholding | 711 | $74K | 3/3/2025 |
| Ian Michael Estepan | ▲ Buy | Option Exercise | 1,533 | $18K | 1/29/2025 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 2,613 | $307K | 1/29/2025 |
| Ian Michael Estepan | ▲ Buy | Option Exercise | 14,267 | $171K | 1/29/2025 |
| Ian Michael Estepan | ▼ Sell | Gift | 250 | $0 | 12/27/2024 |
| Hans Lennart Rudolf Wigzell | ▲ Buy | Option Exercise | 10,500 | $144K | 12/12/2024 |
| Hans Lennart Rudolf Wigzell | ▼ Sell | Open Market | 10,500 | $1.3M | 12/12/2024 |
| Kathryn Jean Boor | ▼ Sell | Open Market | 1,636 | $205K | 12/5/2024 |
| Cristin Rothfuss | ▲ Buy | Grant | 2,000 | $0 | 11/26/2024 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 4,558 | $469K | 11/18/2024 |
| Deirdre P. Connelly | ▲ Buy | Grant | 2,842 | $0 | 9/12/2024 |
| M. Kathleen Behrens | ▼ Sell | Gift | 746 | $0 | 9/4/2024 |
| Ian Michael Estepan | ▼ Sell | Open Market | 5,985 | $822K | 8/30/2024 |
| Michael Andrew Chambers | ▲ Buy | Open Market | 13,106 | $1.7M | 8/16/2024 |
| Michael Andrew Chambers | ▲ Buy | Open Market | 18,284 | $2.5M | 8/16/2024 |
| Michael Andrew Chambers | ▲ Buy | Open Market | 5,648 | $761K | 8/16/2024 |
| M. Kathleen Behrens | ▲ Buy | Option Exercise | 15,000 | $209K | 7/3/2024 |
| Brown Ryan Edward | ▼ Sell | Open Market | 17,581 | $2.9M | 6/25/2024 |
| Brown Ryan Edward | ▼ Sell | Open Market | 3,840 | $628K | 6/25/2024 |
| Brown Ryan Edward | ▼ Sell | Open Market | 2,549 | $419K | 6/25/2024 |
| Brown Ryan Edward | ▲ Buy | Option Exercise | 23,500 | $1.5M | 6/25/2024 |
| Brown Ryan Edward | ▼ Sell | Open Market | 7,644 | $1.2M | 6/25/2024 |
| Brown Ryan Edward | ▼ Sell | Open Market | 2,200 | $350K | 6/25/2024 |
| Brown Ryan Edward | ▼ Sell | Open Market | 975 | $156K | 6/25/2024 |
| Brown Ryan Edward | ▼ Sell | Open Market | 4,168 | $674K | 6/25/2024 |
| Arif Bilal | ▼ Sell | Open Market | 3,898 | $636K | 6/25/2024 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 2,182 | $359K | 6/24/2024 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 2,483 | $409K | 6/24/2024 |
| Arif Bilal | ▼ Sell | Tax Withholding | 2,352 | $387K | 6/24/2024 |
| Murray Dallan | ▼ Sell | Tax Withholding | 2,352 | $387K | 6/24/2024 |
| Arif Bilal | ▼ Sell | Open Market | 5,580 | $906K | 6/24/2024 |
| Brown Ryan Edward | ▼ Sell | Tax Withholding | 2,352 | $387K | 6/24/2024 |
| Arif Bilal | ▼ Sell | Open Market | 1,055 | $173K | 6/24/2024 |
| Arif Bilal | ▼ Sell | Open Market | 300 | $49K | 6/24/2024 |
| Arif Bilal | ▼ Sell | Open Market | 700 | $116K | 6/24/2024 |
| Arif Bilal | ▼ Sell | Open Market | 224 | $37K | 6/24/2024 |
| Arif Bilal | ▲ Buy | Option Exercise | 6,250 | — | 6/21/2024 |
| Louise Rodino-Klapac | ▲ Buy | Option Exercise | 6,250 | — | 6/21/2024 |
| Ian Michael Estepan | ▲ Buy | Option Exercise | 6,250 | — | 6/21/2024 |
| Murray Dallan | ▲ Buy | Option Exercise | 6,250 | — | 6/21/2024 |
| Brown Ryan Edward | ▲ Buy | Option Exercise | 6,250 | — | 6/21/2024 |
| Murray Dallan | ▼ Sell | Open Market | 3,635 | $509K | 5/2/2024 |
| Kathryn Jean Boor | ▼ Sell | Open Market | 761 | $94K | 3/11/2024 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 1,035 | $127K | 3/8/2024 |
| Arif Bilal | ▼ Sell | Tax Withholding | 472 | $58K | 3/8/2024 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 909 | $112K | 3/8/2024 |
| Brown Ryan Edward | ▼ Sell | Tax Withholding | 899 | $111K | 3/8/2024 |
| Hans Lennart Rudolf Wigzell | ▲ Buy | Option Exercise | 15,000 | $209K | 3/8/2024 |
| Hans Lennart Rudolf Wigzell | ▼ Sell | Open Market | 11,745 | $1.4M | 3/8/2024 |
| Hans Lennart Rudolf Wigzell | ▼ Sell | Open Market | 100 | $12K | 3/8/2024 |
| Hans Lennart Rudolf Wigzell | ▼ Sell | Open Market | 3,155 | $391K | 3/8/2024 |
| Arif Bilal | ▼ Sell | Tax Withholding | 506 | $61K | 3/7/2024 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 512 | $62K | 3/7/2024 |
| Brown Ryan Edward | ▼ Sell | Tax Withholding | 506 | $61K | 3/7/2024 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 526 | $63K | 3/7/2024 |
| Stephen Mayo | ▼ Sell | Open Market | 3,135 | $385K | 3/5/2024 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 1,389 | $174K | 3/4/2024 |
| Brown Ryan Edward | ▼ Sell | Tax Withholding | 1,734 | $217K | 3/4/2024 |
| Arif Bilal | ▼ Sell | Tax Withholding | 285 | $36K | 3/4/2024 |
| Arif Bilal | ▼ Sell | Tax Withholding | 237 | $30K | 3/4/2024 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 1,728 | $217K | 3/4/2024 |
| Stephen Mayo | ▲ Buy | Grant | 1,846 | $0 | 3/1/2024 |
| Hans Lennart Rudolf Wigzell | ▲ Buy | Grant | 1,846 | $0 | 3/1/2024 |
| M. Kathleen Behrens | ▲ Buy | Grant | 1,846 | $0 | 3/1/2024 |
| Arif Bilal | ▼ Sell | Tax Withholding | 251 | $32K | 3/1/2024 |
| Arif Bilal | ▲ Buy | Grant | 6,000 | $0 | 3/1/2024 |
| Arif Bilal | ▼ Sell | Open Market | 1,543 | $198K | 3/1/2024 |
| Arif Bilal | ▼ Sell | Open Market | 457 | $59K | 3/1/2024 |
| Arif Bilal | ▼ Sell | Tax Withholding | 114 | $14K | 3/1/2024 |
| Kathryn Jean Boor | ▲ Buy | Grant | 1,846 | $0 | 3/1/2024 |
| Ian Michael Estepan | ▼ Sell | Tax Withholding | 365 | $46K | 3/1/2024 |
| Ian Michael Estepan | ▼ Sell | Open Market | 1,200 | $154K | 3/1/2024 |
| Brown Ryan Edward | ▼ Sell | Tax Withholding | 269 | $34K | 3/1/2024 |
| Brown Ryan Edward | ▼ Sell | Open Market | 2,000 | $251K | 3/1/2024 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 778 | $98K | 3/1/2024 |
| Richard Barry | ▲ Buy | Grant | 1,846 | $0 | 3/1/2024 |
| Ian Michael Estepan | ▲ Buy | Grant | 6,000 | $0 | 3/1/2024 |
| Michael Andrew Chambers | ▲ Buy | Grant | 1,846 | $0 | 3/1/2024 |
| Brown Ryan Edward | ▲ Buy | Grant | 6,000 | $0 | 3/1/2024 |
| Claude Nicaise | ▲ Buy | Grant | 1,846 | $0 | 3/1/2024 |
| Louise Rodino-Klapac | ▲ Buy | Grant | 6,000 | $0 | 3/1/2024 |
| Arif Bilal | ▼ Sell | Tax Withholding | 3,682 | $296K | 12/1/2023 |
| Louise Rodino-Klapac | ▼ Sell | Tax Withholding | 4,508 | $374K | 11/17/2023 |
| Douglas S. Ingram | ▲ Buy | Open Market | 10,081 | $792K | 11/3/2023 |
| Douglas S. Ingram | ▲ Buy | Open Market | 200 | $16K | 11/3/2023 |
| M. Kathleen Behrens | ▲ Buy | Option Exercise | 15,000 | $435K | 11/3/2023 |
| Richard Barry | ▲ Buy | Open Market | 40,000 | $3.2M | 11/3/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Sarepta Shares New DM1 Data at Oligonucleotide Meeting
Sarepta Therapeutics presented new preclinical data for SRP-1003, a treatment for myotonic dystrophy type 1, at the 2026 Oligonucleotide Therapeutics Society Annual Meeting. The data indicated robust knockdown of pathogenic DMPK RNA in the nucleus. This update highlights the company's ongoing research efforts, while the stock currently trades near its 52-week low with a volume spike.
Sarepta Shares New DM1 Data at Oligonucleotide Meeting. Sarepta Therapeutics presented new preclinical data for SRP-1003, a treatment for myotonic dystrophy type 1, at the 2026 Oligonucleotide Therapeutics Society Annual Meeting. The data indicated robust knockdown of pathogenic DMPK RNA in the nucleus. This update highlights the company's ongoing research efforts, while the stock currently trades near its 52-week low with a volume spike.